Skip to main content

Table 3 Metabolic syndrome parameters

From: Effects of lifestyle changes including specific dietary intervention and physical activity in the management of patients with chronic hepatitis C - a randomized trial

 

NGLCD

LFD

 

Baseline

12 months

Mean change

Baseline

12 months

Mean change

WC (cm)

92.7 ± 13.6

89.5 ± 11.9

−3.3 ± 3.6 [−4.3, -2.3]

92.4 ± 11.7

89 ± 10.6

−3.4 ± 3.1 [−6.7, -0.96]

BMI (kg/m2)

29.4 ± 3.5

28.9 ± 3.6

−1.4 ± 1.1 [−1.7, -1.1]

29.4 ± 3.4

28.3 ± 3.4

−1.1 ± 0.9 [−1.3, -0.8]

Weight (kg)

84.07 ± 13.2

80.09 ± 13.8

−3.9 ± 3.3 [−4.8, -3.1]

83 ± 11.1

79.8 ± 11.5

−3.1 ± 2.6 [−3.8, -2.3]

Triglycerides (mg/dl)

157.4 ± 50.8

128.5 ± 31

−28.9 ± 5.09 [−39.1, -18.8]

164.6 ± 47.8

134.1 ± 32.3

−30.4 ± 38.7 [−41.2, -19.7]

HDL-cholesterol (mg/dl)

42.7 ± 11.3

46 ± 10.2

3.3 ± 3.8 [4.3-2.3]

42.3 ± 10.3

46.7 ± 8.9

4.4 ± 4.03 [3.3, 5.5]

FPG (mg/dl)

104.1 ± 27.9

96.9 ± 19.7

−7.2 ± 11.2 [−10.2, -4.2]

103.7 ± 29.2

96.5 ± 19.1

−7.2 ± 13.1 [−10.8, -3.5]

Cholesterol (mg/dl)

212.4 ± 40.4

190.2 ±20.2

−22.1 ± 28.6 [−29.5, -14.7]

209.1 ± 37

185 ± 16

−24.1 ± 27.5 [−31.8, -16.4]

SBP (mmHg)

130.8 ± 11.2

125.9 ± 12.4

−4.8 ± 8.7 [−6.9,-2.7]

143.7 ± 12.2

129.4 ± 11.2

−4.9 ± 6.1 [−6.5, -3.3]

DBP (mmHg)

78.8 ±8.04

76.1 ± 8.6

−2.6 ± 10.6 [−5.2,-0.06]

84.8 ± 9.7

76.7 ± 10.3

−3.8 ± 11.1 [−6.7, -0.96]

  1. Values are means ± SD; for mean change the results were expressed as means ± SD and 95% confidence intervals.
  2. NGLCD normoglucidic low-calorie diet, LFD low-fat diet, WC waist circumference, BMI body mass index, HDL high density lipoproteins, FPG fasting plasma glucose, SBP systolic blood pressure, DBP diastolic blood pressure.
  3. All p < 0.005 for within group change from baseline to 12 months; All p >0.05 for difference between groups at baseline and 12 months.